Bruker Introduces the Ingenious Novel ‘Triceratops' SPR #64 Surface Plasmon Resonance System for Drug Discovery at SLAS2024Business Wire • 02/05/24
Bruker (BRKR) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research • 02/01/24
Bruker Corporation (BRKR) 42nd Annual J.P. Morgan Healthcare Conference (Transcript)Seeking Alpha • 01/10/24
Bruker Announces Acquisition of Tornado Spectral Systems to Expand Its Biopharma Process Analytical Technology (PAT) Product PortfolioBusiness Wire • 01/04/24
Bruker Corporation to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceBusiness Wire • 01/03/24
Bruker Announces First 1.2 GHz NMR Installation in the United States at The Ohio State University - Funded by the U.S. National Science FoundationBusiness Wire • 12/19/23
Accelerate Diagnostics Announces Collaboration for the Use of the Arc™ System in Combination With Bruker´s MALDI Biotyper®PRNewsWire • 11/27/23
Bruker Corporation to Participate in the 2023 Jefferies London Healthcare ConferenceBusiness Wire • 11/07/23
Bruker Announces Date and Time of Third Quarter 2023 Earnings Release and WebcastBusiness Wire • 10/27/23
Bruker (BRKR) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 ReleaseZacks Investment Research • 10/26/23
Bruker: Economic Principles Indicate Dislocation To Market-Implied ExpectationsSeeking Alpha • 10/24/23
Valo Therapeutics Announces Acquisition of Bruker Corporation's Latest Mass Spectrometer Platform for Tumor Antigen Identification with ValoTx's PeptiCHIP TechnologyGlobeNewsWire • 10/10/23